Design method and application of high-fidelity nucleic acid amplification primer

By modifying the photoresponsive group and the 3' terminal blocking group on the nucleic acid amplification primer, the pre-amplification problem in nucleic acid amplification technology is solved, and the nucleic acid amplification reaction is achieved The precise and rapid regulation is suitable for various nucleic acid amplification technologies, improving sensitivity and application convenience.

CN119020472APending Publication Date: 2024-11-26CHONGQING MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411288716.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Among the existing nucleic acid amplification technologies, especially PCR and isothermal nucleic acid amplification technologies, they are prone to pre-amplification problems during the system premixing process, which reduces sensitivity and efficiency, and has high equipment dependence, which limits its application.

Method used

Design a high-fidelity nucleic acid amplification primer to form a photocontrol primer by modifying the photoresponsive group and the 3' terminal blocking group on the primer, activate the photoresponsive group bond breaking using a light source of a specific wavelength, and pass the exonuclease The dephosphorylation of the primer restores the extension function, thereby achieving accurate initiation and rapid amplification.

Benefits of technology

It effectively solves the pre-amplification problem, realizes accurate and rapid regulation of nucleic acid amplification reaction, and is suitable for various nucleic acid amplification technologies without adjustment, improving sensitivity and application convenience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020472A_ABST
    Figure CN119020472A_ABST
Patent Text Reader

Abstract

The invention relates to a high-fidelity nucleic acid amplification primer design method and application, and the method comprises the following steps: S1, modifying a photoresponse group and a 3'terminal blocking group on a primer to form a light-controlled primer, which can silence a polymerase-guided primer extension reaction; and S2, irradiating the light-operated primer by using a light source with a specific wavelength to separate the light response group, and generating a 3 '-OH group through a dephosphorizing process to recover the extension function of the light-operated primer so as to start nucleic acid amplification. S3, combining the designed high-fidelity nucleic acid amplification primer with a conventional nucleic acid amplification technology to construct a detection method. According to the invention, the problem of pre-amplification caused by reaction components in a premixing process can be effectively solved through a dual activation mode of light control and dephosphorylation. According to the high-fidelity primer design method, accurate and rapid regulation and control of nucleic acid amplification reaction can be realized in time and space; meanwhile, the used primer extension regulation and control method is high in universality, is suitable for all nucleic acid amplification reactions, and does not need to be adjusted according to different amplification reactions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of molecular diagnosis technology, and in particular to a high-fidelity nucleic acid amplification primer design method and application. Background Art

[0002] Nucleic acids are essential to living organisms. They not only store genetic information and encode proteins, but are also used as important biomarkers in medical diagnosis, forensic identification, food safety testing and other fields. Molecular biology techniques that use DNA or RNA as detection targets have fast analysis speed and high sensitivity and are widely used in early diagnosis of diseases. Nucleic acid amplification technology can enrich the target gene by about a million times, increase the nucleic acid concentration to a detectable level, and has higher sensitivity and specificity.

[0003] As one of the most important technological inventions in the field of molecular biology, polymerase chain reaction (PCR) technology is considered the "gold standard" for amplifying and detecting specific nucleic acid sequences through thermal cycling. After it was first proposed, it quickly developed into a highly sensitive and rapid method for in vitro analysis of nucleic acids. PCR is a cyclic process of amplifying template DNA through two or three different incubation temperatures. First, high temperatures such as 95°C are used for melting, followed by annealing at a temperature of about 55°C and extension at a temperature of about 70°C. However, when the melting temperature is not reached, the primers may use the incompletely melted DNA as a template, resulting in problems such as nonspecific PCR amplification. And because PCR relies on heat-resistant DNA polymerases and expensive thermal cyclers, its application is limited under conditions of limited resources.

[0004] With the development of society, the demand for point-of-care testing (POCT) is increasing. Since PCR requires a thermal cycle system and supporting equipment, its application is limited. However, isothermal nucleic acid amplification technology has the advantages of being fast, efficient, and specific, and does not require dedicated equipment. Therefore, as soon as it appeared, many scholars believed that it was a detection method that could be comparable to qPCR, but its promotion and application still needs further optimization. Among the many emerging isothermal nucleic acid amplification technologies, taking recombinase polymerase amplification (RPA) technology as an example, RPA technology has the advantages of low reaction temperature and high amplification efficiency. However, the RPA reaction is not a hot-start but a chemically started amplification process, which will cause pre-amplification problems during the system premixing process, reducing the sensitivity of RPA.

[0005] In summary, developing a high-fidelity primer design method that can effectively solve the problem of pre-amplification and applying it to nucleic acid amplification technology is an important research direction in this field. Summary of the invention

[0006] Based on this, the purpose of the present invention is to provide a high-fidelity nucleic acid amplification primer design method, which can effectively solve the problem of pre-amplification during the system premixing process. Combining it with conventional nucleic acid amplification technology has the advantages of accurate start-up, rapid and convenient operation.

[0007] To achieve the above object, the present invention is implemented by the following technical method, including the following steps:

[0008] S1, modifying the photoresponsive group and the 3'-terminal blocking group on the primer to form a light-controlled primer, which can silence the polymerase-guided primer extension reaction;

[0009] S2, using a light source of a specific wavelength to irradiate the light-controlled primer to dissociate the light-responsive group, and then generating a 3'-OH group through a dephosphorylation process, so that the light-controlled primer can restore its extension function, thereby initiating nucleic acid amplification;

[0010] S3. Combine the designed high-fidelity nucleic acid amplification primers with conventional nucleic acid amplification technology to construct a detection method.

[0011] The light-controlled primers in step S1 are designed according to the target nucleic acid sequence and have a length of 5 to 100 nt;

[0012] Furthermore, the light-controlled primer is a nucleotide sequence having at least two modifications, a light-responsive group and a 3'-terminal blocking group, which can silence the primer extension reaction guided by the polymerase;

[0013] Furthermore, the light-controlled primer is composed of a primer part that is completely complementary to the target and a mismatch part that is not complementary to the target. The light-responsive group connects the two parts, and the 3' terminal blocking group is modified at the 3' end of the light-controlled primer;

[0014] Furthermore, the photoresponsive group is a photolytic group, selected from at least one of o-nitrobenzyl and its derivatives, coumarin and its derivatives, which can remain stable under natural light;

[0015] Furthermore, the number of modified photoresponsive groups in the light-controllable primer is 1 to 100;

[0016] Furthermore, in the light-controlled primer, a light-responsive group is embedded and modified every 1 to 100 bases;

[0017] Furthermore, the 3' terminal blocking group is selected from at least one of amino, C3 Spacer, and biotin-TEG, and the number of modifications is at least 1;

[0018] Furthermore, the photoresponsive group has a light-induced bond-breaking property, and after being irradiated with a light source of a specific wavelength, the bond is broken, and the photoresponsive group is separated from the primer to generate a 3'-terminal phosphate group. Subsequently, the phosphate group at the 3'-terminal is removed through a dephosphorylation process to generate a 3'-OH group, thereby restoring the extension function of the primer and initiating nucleic acid amplification;

[0019] The light source of the specific wavelength in step S2 is related to the characteristics of the photoresponsive group and can be adjusted according to different characteristics;

[0020] The irradiation time in step S2 is determined according to the light source of a specific wavelength. The greater the light source power, the shorter the required irradiation time, and vice versa. The irradiation time of the light source at 365nm is at least 1s.

[0021] The final concentration of the exonuclease in step S2 is 0.001U / μL to 10U / μL;

[0022] The high-fidelity nucleic acid amplification primer design method described in step S3 can be combined with conventional nucleic acid amplification technology to construct a detection method, such as PCR technology or isothermal amplification technology; the conventional isothermal amplification technology is selected from recombinase polymerase isothermal amplification (RPA), strand displacement amplification (SDA), rolling circle amplification (RCA), loop-mediated isothermal amplification (LAMP), helicase-dependent isothermal amplification (HAD), and nucleic acid sequence-dependent amplification (NASBA).

[0023] Beneficial effects: The present invention designs high-fidelity nucleic acid amplification primers, which can silence the primer extension reaction guided by the polymerase by modifying the photoresponsive group and the 3' terminal blocking group on the primer; the photoresponsive group has the characteristic of photo-breaking bonds, and after being irradiated by a light source of a specific wavelength, the photoresponsive group detaches from the primer. Therefore, when it is necessary to start the amplification reaction, it is only necessary to irradiate with a light source of a specific wavelength to detach the photoresponsive group, and then restore the extension function of the primer through the dephosphorylation of the exonuclease, thereby starting the nucleic acid amplification reaction. The dual activation method of light control and dephosphorylation can effectively solve the pre-amplification problem caused by the reaction components during the premixing process.

[0024] The high-fidelity nucleic acid amplification primer design method of the present invention can achieve accurate and rapid regulation of nucleic acid amplification reactions in time and space; at the same time, the primer extension regulation method used is highly versatile and applicable to all nucleic acid amplification reactions without the need for adjustment according to different amplification reactions.

[0025] For better understanding and implementation, the present invention is described in detail below with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 Schematic diagram of the principle of the method for designing high-fidelity nucleic acid amplification primers according to an embodiment of the present invention;

[0027] Figure 2 is a graph showing the gel electrophoresis results before and after the regulation of the high-fidelity nucleic acid amplification primers described in Example 1;

[0028] Figure 3 is a schematic diagram of the fluorescence signal curve of the high-fidelity PCR described in Example 2;

[0029] Figure 4 is a schematic diagram of the fluorescence signal curve of the high-fidelity recombinase-mediated isothermal rapid amplification described in Example 3; DETAILED DESCRIPTION

[0030] In order to make the purpose, method and effect of the present invention clearer and more specific, the present invention is further described in detail below. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0031] The present invention provides a method and application for designing high-fidelity nucleic acid amplification primers, comprising the following steps:

[0032] S1, modifying the photoresponsive group and the 3'-terminal blocking group on the primer to form a light-controlled primer, which can silence the polymerase-guided primer extension reaction;

[0033] Step S1: The light-controlled primer is designed according to the target sequence, and the 3' end of the light-controlled primer has at least a light-responsive group and a 3' terminal blocking group, wherein the light-responsive group is o-nitrobenzyl (PC-linker), and the 3' terminal blocking group is an amino group;

[0034] S2. Use a light source of a specific wavelength to irradiate the photo-controlled primer to dissociate the light-responsive group, and then the exonuclease generates a 3'-OH group, so that the photo-controlled primer recovers the extension function, thereby initiating nucleic acid amplification.

[0035] The light source of the specific wavelength in step S2 is a 35W 365nm ultraviolet light source, and the irradiation time is preferably 60s;

[0036] After being irradiated by a light source of a specific wavelength, the bond is broken, and the photoresponsive group is separated from the primer. Subsequently, a specific enzyme catalyzes the dephosphorylation process to generate a 3'-OH group.

[0037] After irradiation with a 365nm ultraviolet light source, the PC-linker breaks the bond, generating a 3'-terminal phosphate group. Subsequently, the exonuclease III in the reaction system removes the 3'-terminal phosphate group through dephosphorylation, generating a 3'-OH group, restoring the extension function of the primer, thereby initiating nucleic acid amplification;

[0038] S3. Combine the designed high-fidelity nucleic acid amplification primers with conventional nucleic acid amplification technology to construct a detection method.

[0039] Figure 1 The schematic diagram of the principle of a high-fidelity nucleic acid amplification primer design method according to an embodiment of the present invention is shown. First, a light-responsive group and a 3'-terminal blocking group are modified on the primer to form a light-controlled primer. The dual activation method of light control and dephosphorylation can effectively solve the pre-amplification problem caused by the reaction components during the premixing process. That is, the extension activity is temporarily silenced by modifying the light-responsive group and the 3'-terminal amino group, thereby silencing the nucleic acid amplification. After irradiation with a 365nm ultraviolet light source, the light-responsive group breaks the bond and produces a 3'-terminal phosphate group. Subsequently, the exonuclease III in the reaction system exerts a dephosphorylation effect to remove the phosphate group at the 3'-terminal, produce a 3'-OH group, restore the extension function of the primer, and thus start isothermal nucleic acid amplification.

[0040] In the following specific embodiments, the present invention combines the design method of high-fidelity nucleic acid amplification primers with nucleic acid amplification technology, and describes in detail the high-fidelity PCR and recombinase-mediated constant temperature rapid amplification detection method. For other amplification reactions, the specific principles are similar and will not be repeated in the description of the embodiments of the present invention.

[0041] Example 1

[0042] Embodiment 1 of the present invention provides a method for regulating a high-fidelity light-controlled primer, which specifically includes the following contents:

[0043] (1) Mix the light-controlled primer / conventional primer, exonuclease III and enzyme-free water to prepare a reaction solution.

[0044] In the reaction solution: the final concentration of the light-controlled primer / conventional primer is 200 nM, and the final concentration of exonuclease III is 0.004 U / μL.

[0045] Among them, nuclease exonuclease III was purchased from New England Biotechnology (Beijing) Co., Ltd. (catalog number M0206L).

[0046] In this example, the light-controlled primer E-PC and conventional primer ER sequences used were purchased from Sangon Biotech Co., Ltd. (hereinafter the same), and the relevant sequence information is shown in Table 1:

[0047] Table 1

[0048] Primer name Sequence (5'-3') ER TTTATAAGCTCGCACGGATCTGTGAAGGCA(SEQ ID NO.1) E-MIS TTTATAAGCTCGCACGGATCTGTGAAGGCATAGT(SEQ ID NO.2) E-PC TTTATAAGCTCGCACGGATCTGTGAAGGCA / iPCLink / TAGT[3'-NH2 C6]

[0049] As described in the table above, the light-controlled primer E-PC used in this embodiment is designed according to the target sequence, and its sequence information is the same as SEQ ID NO.2, and four mismatched bases are added after the light-responsive molecule. The specific modification positions and embedded connection positions are detailed in the table above.

[0050] (2) Transfer the PCR tube containing the above reaction solution to a PCR instrument for incubation.

[0051] The incubation reaction program was set as follows: incubate at 37° C. for 30 min. Then, UV light was started to irradiate the reaction system for 1 min.

[0052] (3) The obtained primers before and after regulation were analyzed by polyacrylamide gel electrophoresis. The analysis results were as follows: Figure 2 shown.

[0053] like Figure 2 As shown, lanes 1 and 2 are the non-illumination group, wherein lane 1 is a light-controlled primer without enzyme, and lane 2 is a light-controlled primer with enzyme; lanes 3 and 4 are the illumination group given illumination for 50 s, wherein lane 3 is a light-controlled primer without enzyme, and lane 4 is a light-controlled primer with enzyme; lanes 5 and 6 are the illumination group given illumination for 100 s, wherein lane 5 is a light-controlled primer without enzyme, and lane 6 is a light-controlled primer with enzyme; lanes 7 and 8 are the normal group, wherein lane 7 is a conventional primer without enzyme, and lane 8 is a conventional primer with enzyme.

[0054] like Figure 2 As shown in the polyacrylamide gel electrophoresis results of the regulated light-controlled primers, only when light and exonuclease III are present at the same time, the light-responsive primers can be restored to be almost the same as the conventional primers. In the normal group, the addition of exonuclease III does not affect the conventional primers. This shows that after regulation, the light-controlled primers can be silenced and the extension activity can be restored.

[0055] Example 2

[0056] Example 2 of the present invention provides a high-fidelity PCR detection method to verify the feasibility of a one-tube nucleic acid detection method developed based on a high-fidelity PCR system constructed with light-controlled primers, which specifically includes the following contents:

[0057] (1) 2X SYBR Green Pro Taq HS Premix, a pair of light-controlled primers / conventional primers, and an amplification template are mixed to prepare an amplification reaction solution.

[0058] In the amplification reaction solution: the final concentration of 2X SYBR Green Pro Taq HS Premix is ​​1X, the final concentration of conventional primers is 200 nM, the final concentration of light-controlled primers is 200 nM, the final concentration of amplification template is 50 fg / μL, and the final concentration of exonuclease III is 0.02 U / μL.

[0059] Among them, 2X SYBR Green Pro Taq HS Premix was purchased from Aikerui Biotechnology Co., Ltd. (Cat. No. AG11701).

[0060] The target nucleic acid described in this example is a plasmid containing the gene sequence of Plasmodium (EMP1) (genome coordinates: 28490-28743, GenBank: NC_037281.1, purchased from Sangon Biotechnology Co., Ltd., the same below).

[0061] In this example, the sequences used were purchased from Sangon Biotechnology Co., Ltd. (hereinafter the same), and the relevant sequence information is shown in Table 2:

[0062] Table 2

[0063]

[0064] (2) The PCR tube containing the amplification reaction solution was irradiated with UV light for 1 min, incubated at 37° C. for 30 min in a PCR instrument, and then amplified.

[0065] The PCR amplification reaction program was set as follows: pre-denaturation at 95°C for 30s, followed by 35 cycles of amplification reaction at 95°C for 5s and 62°C for 30s, and finally extension at 72°C for 2min.

[0066] (3) Analyze the obtained real-time PCR results. Figure 3 shown.

[0067] like Figure 3 As shown, the LIGHT group is the illumination group of high-fidelity PCR; the BLOCKED group is the non-illumination group of high-fidelity PCR; the P group is the positive group of conventional PCR; and the NTC is the negative group of high-fidelity PCR.

[0068] like Figure 3 As shown, in the high-fidelity PCR, the experimental group treated with light and the conventional PCR experimental group had amplification curves, while the experimental group without light treatment and the negative control group had no amplification curves. At the same time, in the conventional PCR reaction, light treatment did not affect its reaction efficiency.

[0069] Example 3

[0070] In the implementation of the present invention, a high-fidelity recombinase-mediated constant temperature rapid amplification detection method is provided to verify the feasibility of a one-tube nucleic acid detection method developed based on a high-fidelity recombinase-mediated constant temperature rapid amplification system constructed with light-controlled primers, as follows:

[0071] (1) Prepare a recombinase-mediated constant temperature rapid amplification reaction system.

[0072] The preparation method of the reaction system is as follows: first, use 29.4μL A buffer to resuspend the constant temperature rapid amplification dry powder in a reaction tube, and add 2μL of 10μM conventional primers, 2μL of 10μM light-controlled primers (can be any of the front and back primers), 0.6μL of 10μM fluorescent probe, 3.2μL RNase free water, 5μL of 1pg / μL template and 2.5μL of 280mM magnesium acetate.

[0073] Among them, A buffer, constant temperature rapid amplification dry powder and 280mM magnesium acetate are all from the Amp Future DNA Constant Temperature Rapid Amplification Kit (Cat. No. WLE8202KIT).

[0074] In this example, the sequences used were purchased from Sangon Biotechnology Co., Ltd., and the relevant sequence information is shown in Table 3:

[0075] Table 3

[0076]

[0077] As described in the above table, the fluorescent probe used in this embodiment is a single-stranded DNA designed according to the target sequence, and its sequence information is the same as SEQ ID NO.5, wherein HEX is a fluorescent group, THF is tetrahydrofuran, BHQ1 is a quenching group, and C3 Spacer is a terminal blocking group. The specific modification positions and embedded connection positions are detailed in the above table.

[0078] (2) The reaction tube containing the above amplification reaction was started to irradiate the reaction system with UV light for 1 minute, and then transferred to a PCR instrument for amplification. The amplification reaction conditions for the recombinase-mediated isothermal rapid amplification were: 39°C, 20 minutes.

[0079] (3) Analyze the results of the real-time recombinase-mediated isothermal rapid amplification. Figure 4 shown.

[0080] like Figure 4As shown, the LIGHT group is the illumination group of isothermal rapid amplification mediated by high-fidelity recombinase; the BLOCKED group is the non-illumination group of isothermal rapid amplification mediated by high-fidelity recombinase; the P group is the positive group of isothermal rapid amplification mediated by conventional recombinase; and the NTC is the negative group of isothermal rapid amplification mediated by high-fidelity recombinase.

[0081] like Figure 4 As shown, in the isothermal rapid amplification mediated by high-fidelity recombinase, amplification curves appeared in the experimental group treated with light and the experimental group treated with conventional recombinase, while there were no amplification curves in the experimental group without light treatment and the negative control group. At the same time, in the isothermal rapid amplification reaction mediated by conventional recombinase, light treatment did not affect its reaction efficiency.

[0082] The above-mentioned embodiments only express several implementation methods of the present invention, and the description is relatively specific and detailed, but it cannot be understood as limiting the scope of the invention patent. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A high-fidelity nucleic acid amplification primer design method and application, characterized in that: The following steps are involved: S1, modifying the photoresponsive group and the 3'-terminal blocking group on the primer to form a light-controlled primer, which can silence the polymerase-guided primer extension reaction; S2, using a light source of a specific wavelength to irradiate the light-controlled primer to dissociate the light-responsive group, and then generating a 3'-OH group through a dephosphorylation process, so that the light-controlled primer can restore its extension function, thereby initiating nucleic acid amplification; S3. Combine the designed high-fidelity nucleic acid amplification primers with conventional nucleic acid amplification technology to construct a detection method. The light-controlled primer is a nucleotide sequence having at least two modifications, a light-responsive group and a 3'-terminal blocking group, which temporarily silences the primer extension function. The photoresponsive group has a light-induced bond-breaking property, and after being irradiated with a light source of a specific wavelength, the bond is broken, and the photoresponsive group is separated from the primer to generate a 3'-terminal phosphate group. Subsequently, the phosphate group at the 3'-terminal is removed through a dephosphorylation process to generate a 3'-OH group, thereby restoring the extension function of the primer and initiating nucleic acid amplification.

2. The method and application of high-fidelity nucleic acid amplification primer design according to claim 1, characterized in that: The photoresponsive group is a photolytic group, selected from at least one of o-nitrobenzyl and its derivatives, coumarin and its derivatives, and can remain stable under natural light; The light-controlled primer is designed according to the target nucleic acid sequence and has a length of 5 to 100 nt. The number of modified photoresponsive groups in the light-controlled primer is 1 to 100; In the light-controlled primer, a light-responsive group is embedded and modified every 1 to 100 bases.

3. According to the high-fidelity nucleic acid amplification primer design method and application of claim 1, the 3' terminal blocking group is selected from at least one of amino group, C3 Spacer, and biotin-TEG, and the number of modifications is at least 1.

4. The method and application of high-fidelity nucleic acid amplification primer design according to claim 1, characterized in that: The irradiation time of the specific wavelength light source in step S2 is at least 1 second.

5. The method and application of high-fidelity nucleic acid amplification primer design according to claim 1, characterized in that: The dephosphorylation process is catalyzed by a specific enzyme, and the final concentration of the enzyme is 0.001U / μL to 10U / μL.

6. The method and application of high-fidelity nucleic acid amplification primer design according to claim 1, characterized in that: The high-fidelity nucleic acid amplification primer design method can be combined with conventional nucleic acid amplification technology, such as PCR technology or isothermal amplification technology; the isothermal amplification technology is selected from one of recombinase polymerase isothermal amplification (RPA), strand displacement amplification (SDA), rolling circle amplification (RCA), loop-mediated isothermal amplification (LAMP), helicase-dependent isothermal amplification (HAD), and nucleic acid sequence-dependent amplification (NASBA).